Drug
Lnp1892
Lnp1892: highest development phase Phase 1, developed by Lupin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| LNP1892 NCT02174237 | Phase 1 |
Latest
No recent events.
Follow Lnp1892 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.